An Evaluation of the Bioequivalence of Five 0.1 mg GI198745/Dutasteride Soft Gelatin Capsules Compared to One 0.5 mg GI198745/Dutasteride Gelatin Capsules in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 12 May 2017
At a glance
- Drugs Dutasteride (Primary)
- Indications Alopecia; Benign prostatic hyperplasia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 06 Feb 2014 Status changed to completed as reported by ClinicalTrials.gov record.
- 01 Sep 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 31 Aug 2013 New trial record